Interestingly, PD-1 inhibition has potential to restore CTL induction by a cancer vaccine [49], suggesting that the combination of cancer vaccines and anti-PD-1 may cause long-term tumor remission in patients. The gene discussed is PDCD1; the disease is neoplasm.